EUVIMEDEUVIMED entdecken
Crossref

Longterm outcome of Macroplatique injection for treatment of vesicoureteral reflux in children

Elrahmany A. Mohamed, Farghal H. Shehata, Elemam A. Abdelbaset, Mohamed A. Abdelkhalek, Ashraf H. Abdelatif, Husain A. Galal

African Journal of Paediatric Surgery · 26.05.2026 · 11 (2) · 174-178

DOI: 10.67481/ajps.v11i2.467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift African Journal of Paediatric Surgery, online erschienen am 26.05.2026. Verfasst von Elrahmany A. Mohamed und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study examined our experience with one year follow-up of 20 cases of vesicoureteric reflux in children after treatment with Macroplastique® injection. Patient and Methods: A total of 20 children (31 ureters) with primary grades II to V vesicoureteral reflux were treated with subureteral Macroplastique® injection from 2010 to 2011 and followed for an average of 12 months (range 3 to 24). Vesicoureteral reflux was grade II in 3, III in 7, IV in 9 and V in 12 ureters. Each child underwent pre-operative voiding cystourethrography, abdominopelvic ultrasound, urine analysis/culture, S. creatinine and CBC. Dimercapto-succinic acid scan (DMSA scan) and magnetic resonance urography (MRU) were done in some patients. Voiding cystourethrography at 3 months was done to rule out persistent reflux.

Results

Overall, reflux was corrected in 11 (35.5%) ureters and 9 (45%) children after a single injection. With repeat injection, reflux was corrected in 16 (51.6%) ureters and 11 (55%) children, reflux improved/downgrade in 4 (12.9%) ureters and 2 (10%) children. Correction by grade was 100%, 100%, 9.7%, 9.7% for grades II to V, respectively. There were no surgical complications. None of the cured patients had recurrent reflux during follow-up. There were 9 (45%) children who required open ureteral re-implantation for failed injection.

Conclusion

Sub-ureteral Macroplastique® injection therapy could be a primary treatment for low grade VUR (grade III or less) in children because it is simple, safe, effective, less invasive, decreased.

Zitieren

APA

Mohamed, E. A., Shehata, F. H., Abdelbaset, E. A., Abdelkhalek, M. A., Abdelatif, A. H., & Galal, H. A. (2026). Longterm outcome of Macroplatique injection for treatment of vesicoureteral reflux in children. African Journal of Paediatric Surgery, 11(2), 174-178. https://doi.org/10.67481/ajps.v11i2.467

Vancouver

Mohamed EA, Shehata FH, Abdelbaset EA, Abdelkhalek MA, Abdelatif AH, Galal HA. Longterm outcome of Macroplatique injection for treatment of vesicoureteral reflux in children. African Journal of Paediatric Surgery. 2026;11(2):174-178. doi:10.67481/ajps.v11i2.467

BibTeX
@article{Mohamed2026,
  author = {Mohamed, Elrahmany A. and Shehata, Farghal H. and Abdelbaset, Elemam A. and Abdelkhalek, Mohamed A. and Abdelatif, Ashraf H. and Galal, Husain A.},
  title = {Longterm outcome of Macroplatique injection for treatment of vesicoureteral reflux in children},
  journal = {African Journal of Paediatric Surgery},
  year = {2026},
  volume = {11},
  number = {2},
  pages = {174--178},
  doi = {10.67481/ajps.v11i2.467}
}
Kostenlos starten →